In this segment, Alzheimer’s disease and dementia expert Dr. Danielle Goldfarb talks about clinical trials.
Dr. Goldfarb is a neurologist and psychiatrist, as well as a physician researcher at Banner Sun Health Research Center in Sun Sun City, Arizona. Clinical trials in an option for some patients, and it’s beneficial to participate. Dr. Goldfarb talks about what happens when you’re considering taking part to help determine whether a newly-developed drug is safe, well-tolerated and effective. Visit lift-ad.com for more about the LIFT-AD Phase 2 Study of an Investigational Drug for the Treatment of Mild to Moderate Alzheimer’s Disease. Sponsored by Athira Pharma.
